Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Shuangshi Pharmaceutical Co., Ltd. (also known as Jiangxi Shuangshi AHP) is a Chinese pharmaceutical company specializing in the animal health and veterinary medicine sectors. Based in Nanchang, Jiangxi Province, the company manufactures and markets a variety of products, including liquid injections, disinfectants, and nutritional feed additives for the agricultural market. Historically, the company has operated as the primary subsidiary of Hiru Corporation (OTC: HIRU), supporting its expansion into China's livestock health industry. In 2010, the company established the Jiangxi Shuangshi Biological Medicines Institute to focus on the research and development of novel veterinary drugs and biotechnological solutions. The company continues to maintain manufacturing facilities in the Nanchang Xiaolan Industrial Zone and provides animal nutrition and health solutions across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Shuangshi Pharmaceutical.